🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the clinical response of sirukumab...
Status
Completed
Location
MemorialCare Research Miller Children's and Women's Hospital Long Beach
Start Date
2020-04-24
Trial ID
NCT04380961
Treatments Being Tested
The purpose of the study is to assess the bioavailability (the extent to wh...
Status
Completed
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT02079545
Sirukumab is a fully human anti-interleukin-6 (IL-6) immunoglobulin G1-kapp...
Status
Terminated
Location
GSK Investigational Site
Start Date
2015-10-16
Trial ID
NCT02531633
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of CNTO 13...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01273389
The purpose of this study is to evaluate the long-term safety and efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
2013-08-07
Trial ID
NCT01856309
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of sirukum...
Status
Completed
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT01689532
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of sirukumab as adjun...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-23
Trial ID
NCT02473289
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and how t...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00844909
Treatments Being Tested
The purpose of this study is to assess the efficacy of sirukumab as measure...
Status
Completed
Location
Multiple Locations
Start Date
2012-08-15
Trial ID
NCT01604343
The main purpose of this study was to evaluate the safety and pharmacokinet...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT01702740
Treatments Being Tested